Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 155 (ZNF155) is a member of the C2H2-type zinc-finger transcription factor family and contains a KRAB (Krüppel-associated box) domain[4]. ZNF155 is predicted to function in transcriptional regulation by binding DNA, but its precise biological roles and direct disease associations remain uncharacterized. Like other zinc finger proteins, it likely participates in fundamental cellular mechanisms by modulating gene expression[1][2][4][5][6]. There is currently no evidence that ZNF155 itself serves as a therapeutic target or is directly implicated in human diseases, although the broader ZNF protein family is important in genome stability, transcription, and cancer[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 155 (ZNF155).